摘要:
A data signal to be transmitted is supplied to a modulator of a transmitter, and the modulator modulates the output of a blue light-excited white LED and outputs blue LED light and phosphor light. The modulated blue light enters to a photo-electric converter through an LED light transmission color filter. The modulated phosphor light on the other hand enters to another photo-electric converter through a phosphor light transmission color filter. The photo-electric converters convert incident light to electric signals. The converted signals are amplified by amplifiers. Then, equalizers emphasize the harmonic component therein according to the response characteristic of the blue light and the response characteristic of the phosphor light for reduction of the dullness of waveforms.
摘要:
Provided is an indole long-chain alcohol, or a hydrate or an isomer thereof, represented by the following formula (I): wherein R1, R2, R3 and R4 each independently represent a hydrogen atom, a methyl group, an acetyl group, or a hydroxyl group, and n represents a number from 0 to 20; and a medicinal composition comprising the same. The indole long-chain alcohol (I) exhibits an excellent nerve growth promoting effect, as well as potent antioxidative and anti-tumor effects, and is therefore useful as a prophylactic and/or therapeutic agent for cerebral diseases including dementia diseases, and malignant tumors including brain tumors.
摘要:
A preventive and/or therapeutic agent for diabetes complications, which comprises as an effective ingredient a cyclohexenone long-chain alcoholic derivative represented by the following formula (1): wherein, R1, R2 and R3 each independently represents a hydrogen atom or a methyl group and X represents a linear or branched C10-28 alkylene or alkenylene group. The cyclohexenone long-chain alcoholic derivative of the present invention significantly suppresses a reduction in a peripheral nerve conduction rate and alleviates the hypofunction of the bladder so that it is useful as a preventive and/or therapeutic agent for diabetes complications, particularly, for diabetic neuropathy.
摘要:
It is an object of the present invention to provide a recording condition closer to an optimum even for a medium unknown to a drive, and more particularly to provide a method especially effective when applied to code identification methods, such as PRML, wherein codes are identified based on amplitude information of an RF signal. In order to accomplish the object, an RF signal received from a photo-receiving part 108 of a pickup is converted into sampling data by an A/D converter 300, and a Viterbi decoder 302 performs code determination using the sampling data. Codes included in a reproduction signal are then determined by synchronizing recording pulses with the reproduction signal using the result of the code determination. Then, the result is used to specify a part to be detected in the codes, and finally an amplitude of the specified part is detected.
摘要:
In one inventive aspect, a transmitter is provided. In the transmitter, a modulator supplies an electrical current based on a digital transmission electrical signal to a white LED, which emits light including a plurality of wavelengths into the air. A light detector separates a light signal component having a blue wavelength from the emitted light using an optical filter and converts the signal component to a monitoring electrical signal. A waveform control circuit outputs a control signal so that the time delay of the waveform of the monitoring signal with respect to the waveform of the transmission electrical signal is less than or equal to a predetermined value. The modulator corrects the amount of the electrical current supplied to the white LED on the basis of the control signal. In another inventive aspect, a receiver is provided. In the receiver, an optical filter separates a light signal component having a blue wavelength and a light detector detects substantially only the light signal component having a blue wavelength.
摘要:
The present invention provides a transdermal patch having excellent preservation stability and transdermal absorbency of DMAE or its pharmacologically acceptable salt. The patch has a support and a plaster layer integrally laminated on one surface of the support, and the plaster layer includes: 2-amino-1-(2′,5′-dimethoxyphenyl)ethanol or its pharmacologically acceptable salt; 40 to 98% by weight of acrylic adhesive prepared by copolymerizing monomers respectively containing 30 to 99% by weight of alkyl methacrylate having an alkyl group with a carbon number of 6 to 22 and 1 to 70% by weight of alkyl acrylate having an alkyl group with a carbon number of 2 to 20; and 1 to 30% by weight of saturated aliphatic monohydric alcohol having an alkyl group with a carbon number of 10 to 30.
摘要:
Provided is an indole long-chain alcohol, or a hydrate or an isomer thereof, represented by the following formula (I): wherein R1, R2, R3 and R4 each independently represent a hydrogen atom, a methyl group, an acetyl group, or a hydroxyl group, and n represents a number from 0 to 20; and a medicinal composition comprising the same. The indole long-chain alcohol (I) exhibits an excellent nerve growth promoting effect, as well as potent antioxidative and anti-tumor effects, and is therefore useful as a prophylactic and/or therapeutic agent for cerebral diseases including dementia diseases, and malignant tumors including brain tumors.
摘要:
A protein introduction method with which protein can be introduced into cells with excellent safety is provided. A target protein is supported on a carrier for protein introduction that is made from a clay mineral, and by adding this to cells it is possible to introduce the target protein into the cells. The clay mineral is preferably a layered clay mineral, and as the clay mineral it is possible to use montmorillonite, vermiculite, and illite, for example.
摘要:
Provided is a medicament having an excellent therapeutic effect on ageing macular degeneration. The therapeutic agent for ageing macular degeneration comprises a progesterone derivative represented by the following formula (1): (wherein, R1 represents an alkyl group having from 1 to 23 carbon atoms) as an effective ingredient.
摘要:
The present invention provides a TNF-α production inhibitor containing a kavalactone as an active ingredient, which inhibitor has high safety, exerts an excellent effect of inhibiting TNF-α production, and is useful as a drug or an animal drug for preventing, ameliorating, or treating diseases such as cachexia attributed to cancer or infectious diseases, chronic rheumatoid arthritis, inflammatory diseases, osteoarthritis, systemic lupus erythematosus (SLE), rejection during bone marrow transplantation, multiple organ failure, AIDS, meningitis, hepatitis, and type-II diabetes. The present invention also provides a preventive, ameliorating, or therapeutic agent for diseases caused by abnormal production of TNF-α, the agent containing a kavalactone as an active ingredient.